Vue transversale globale

Toutes les maladies

Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.

Périmètre

Filtrer toute la vue

Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.

Tout réinitialiser Actualisation…
Essais et traitements5743Données cliniques et programmes
Recherches et trouvailles21Pipeline scientifique
Publications4871Références reliées aux maladies
Pistes exploratoires0Hypothèses non validées
10635 résultats correspondants · 41 visibles sur cette page dans le périmètre Toutes les maladies
Niveau clinique

Études et traitements 5743

Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Ablation Treatment with FARAPULSE™ Pulsed Field Ablation (PFA) System… NCT07925359 · NAVigate-ULTRA — The Evaluation of User Experience With FARAVIEW™ Technology of… Maladie coronarienne À vérifier Non applicable NOT_YET_RECRUITING The objective of this study is to obtain experience with new and modified… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
SESAME Procedure NCT07806149 · NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Multi-Center Prospective… Maladie coronarienne Traitement symptomatique Non applicable NOT_YET_RECRUITING This is an early study of a catheter-based minimally invasive procedure ca… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Topical cyanoacrylate tissue adhesive NCT07926191 · Tissue Adhesive Versus Figure-of-Eight Suture for Femoral Venous Closure After E… Maladie coronarienne Thérapie génique À vérifier NOT_YET_RECRUITING In July 2026 the electrophysiology laboratory of a Czech tertiary cardiolo… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Truvaga Plus NCT07926945 · U54: nVNS RCT — Effects of nVNS on Stress Reactivity in IBS Maladie coronarienne Traitement symptomatique Non applicable NOT_YET_RECRUITING Irritable bowel syndrome (IBS) is a chronic disorder of gut-brain interact… À vérifier ClinicalTrials.gov 2026-11-09 21:03:06 Détail
Capstan Compass Robotic System for Transcatheter Mitral Valve Replace… NCT07917208 · Early Feasibility Study of the Capstan Medical TMVR System Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This early feasibility study is evaluating the safety and performance of t… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Discontinuation of aspirin (ATC-code B01AC06 and N02BA01) NCT07854795 · RELEASE-Norway — Reconsidering Long-Term Apirin in the Elderly in Secondary Prev… Maladie coronarienne À vérifier Phase 4 NOT_YET_RECRUITING Lifelong aspirin has been a cornerstone of secondary prevention after coro… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Extracorporeal Shock Wave Therapy NCT07068399 · CSWT — Use of Shock Wave Therapy for Neo-Vascularisation in Non-critical Coronar… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This randomized single-blind controlled trial aims to compare the effectiv… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Modified ultrafiltration NCT00246779 · A Study of the Effect of Blinding in a Trial of Blood Filtration During Heart Su… Maladie coronarienne À vérifier Non applicable COMPLETED Cardiac surgery is a major consumer of blood products worldwide. The natur… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Naproxen NCT07549490 · Human Experimental Models of Pain (HEMP) Maladie coronarienne Immunomodulation · Traitement symptomatique Non applicable NOT_YET_RECRUITING This pilot study will test an innovative way to establish how pain medicin… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Prescription of Aspirin NCT07524335 · ASCAD-P — Aspirin in Subclinical Coronary Artery Disease: A Pilot Randomised Con… Maladie coronarienne À vérifier Phase 3 RECRUITING In patients with subclinical coronary artery disease, the ASCAD-P study ai… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Pulmonary Vein Isolation NCT06402617 · RETRO-AF — Ablation of Focal Activation in Atrial Fibrillation Maladie coronarienne Ralentissement de la progression Non applicable RECRUITING Atrial Fibrillation (AF) and Heart Failure (HF) are colliding global cardi… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Serratus Posterior Superior Intercostal Plane Block With Bupivacaine NCT07588230 · Serratus Posterior Superior Intercostal Plane Block in Minimally Invasive Cardia… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING This randomized, double-blind, placebo-controlled study aims to evaluate t… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
TAVI NCT07926022 · TAVI and PCI in Comparison to SAVR and CABG in Low and Intermediate Risk Patient… Maladie coronarienne À vérifier À vérifier RECRUITING \# WHAT IS THIS STUDY ABOUT? This study compares two different treatment a… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
This study involved an auxillary CE-marked medical device (implantabl… NCT07545512 · ODISSEY — ODSSEY-SCD_Identification Of Markers to preDict the rISk of Sudden Car… Maladie coronarienne Traitement symptomatique Non applicable RECRUITING Although advances in treatment and patient management have considerably im… À vérifier ClinicalTrials.gov 2026-11-09 21:03:05 Détail
Evolocumab NCT05284747 · EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Maladie coronarienne À vérifier Phase 4 ACTIVE_NOT_RECRUITING The primary objective of this study is to evaluate the effectiveness of ea… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
Microaxial flow pump (left ventricular assist device) NCT07762560 · DOUBLE-SHOCK — Routine Microaxial Heart Pump Support and Protocolized Pulmonary… Maladie coronarienne Thérapie génique Non applicable RECRUITING The goal of this clinical trial is to learn which treatment strategies imp… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
No aspirin (Prasugurel monotherapy) NCT05709626 · PREMIUM — PRasugrEl Monotherapy Following prImary percUtaneous Coronary Interven… Maladie coronarienne À vérifier Phase 4 COMPLETED The aim of this study is to evaluate the safety of prasugrel monotherapy w… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
Percutaneous Mechanical Circulatory Support NCT06445608 · PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm Maladie coronarienne À vérifier Non applicable RECRUITING This purpose of this trial is to demonstrate 30 day safety and effectivene… À vérifier ClinicalTrials.gov 2026-11-09 21:03:04 Détail
26G Needle NCT07926113 · MASS-NEEDLE — Comparison of 26G and 30G Needles for Masseter Trigger Point Injec… Myopathies Traitement symptomatique Non applicable NOT_YET_RECRUITING This randomized split-face study aims to compare the effects of 26G and 30… À vérifier ClinicalTrials.gov 2026-11-09 21:02:59 Détail
ABSK021 NCT04192344 · A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in… Myopathies À vérifier Phase 1 RECRUITING This is an open-label phase 1 study to determine the safety and tolebility… À vérifier ClinicalTrials.gov 2026-11-09 21:02:59 Détail
Découverte scientifique

Recherches et trouvailles 21

Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation Sclérose latérale amyotrophique Neuroprotection · Immunomodulation Découverte fondamentale Exploratoire Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… Revue scientifique 2024-07-01 Détail
Bibliographie

Publications 4871

Références bibliographiques de la base locale et accès à leur source originale.

Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Hyperosmolar therapies for neurological deterioration in mild and mod… Sodium Chloride 0.9% Inj · PMID 38468599 Épilepsie À vérifier Publication PubMed Voir la publication source The scoping review by Nicolò Marchesini and colleagues about the use of hyperosmolar therapies (HTs) in patients with t… Brain injury 2026-09-11 23:42:13 Source
Time-dependent efficacy and safety of hypertonic saline versus mannit… Sodium Chloride 0.9% Inj · PMID 41724523 Épilepsie Thérapie génique Publication PubMed Voir la publication source Traumatic brain injury (TBI) represents a significant cause of morbidity and mortality in children, with secondary inju… Brain injury 2026-09-11 23:42:13 Source
Vitamin B Supplementation for Diabetic Peripheral Neuropathy: A Revie… Low Dose Benfotiamine · PMID 42452619 Maladie d’Alzheimer Traitement symptomatique Publication PubMed Voir la publication source Diabetic peripheral neuropathy (DPN) is a common and disabling complication of diabetes. B vitamins play essential role… Journal of clinical medicine 2026-09-11 23:42:10 Source
Chronic adaptive deep brain stimulation in Parkinson's disease: ADAPT… Medtronic Percept Deep Brain Stimulation (cDBS) · PMID 41741462 Maladie de Parkinson Traitement symptomatique Publication PubMed Voir la publication source Deep brain stimulation (DBS) is established for Parkinson's disease (PD), but conventional DBS (cDBS) may yield subopti… NPJ Parkinson's disease 2026-09-11 23:42:09 Source
Effects of theta burst stimulation on the Parkinsonian gait disorder… Medtronic Percept Deep Brain Stimulation (cDBS) · PMID 40383539 Maladie de Parkinson Traitement symptomatique Publication PubMed Voir la publication source BackgroundThe Parkinsonian gait disorder and freezing of gait (FoG) are challenging symptoms of Parkinson's disease (PD… Journal of Parkinson's disease 2026-09-11 23:42:09 Source
Cognitive training effects in mild cognitive impairment with and with… [11C]PIB · PMID 42657170 Maladie d’Alzheimer · Sclérose en plaques Thérapie génique Publication PubMed Voir la publication source Imagery-based cognitive training (CT) is a promising strategy for individuals with amnestic mild cognitive impairment (… Dementia & neuropsychologia 2026-09-11 23:42:05 Source
Decomposition-based harmonization for quantitative PET imaging across… [11C]PIB · PMID 42381155 Maladie d’Alzheimer À vérifier Publication PubMed Voir la publication source Quantitative positron emission tomography (PET) is widely applied in oncology, neuroscience, and clinical practice. How… Medical physics 2026-09-11 23:42:05 Source
Evaluation of increased oxidative stress in the brain of patients wit… [11C]PIB · PMID 41428074 Maladie d’Alzheimer Neuroprotection · Ralentissement de la progression Publication PubMed Voir la publication source We aimed to compare brain oxidative stress (OS) levels between patients with early Alzheimer's disease (eAD) and age-ma… Journal of neural transmission (Vienna, Austria : 1996) 2026-09-11 23:42:05 Source
A novel Mediterranean diet-inspired supplement reduces hippocampal am… Neurodegenerative Diseases Progression Markers (MARKERS-NDD) · PMID 41527932 Maladie d’Alzheimer Neuroprotection · Ralentissement de la progression · Immunomodulation · Thérapi… Publication PubMed Voir la publication source Alzheimer's disease (AD) is projected to increase in prevalence, heightening the need for strategies to alleviate its n… Gut microbes 2026-09-03 16:32:06 Source
Effect of MN-166 (ibudilast) on acute respiratory failure prevention… MN-166 · PMID 41928198 Sclérose latérale amyotrophique À vérifier Publication PubMed Voir la publication source BACKGROUND: MN-166 (ibudilast) is an orally available small molecule drug candidate that inhibits macrophage migration… BMC pulmonary medicine 2026-09-03 16:32:06 Source
Novel cell markers with altered expression in brain aging and Alzheim… Neurodegenerative Diseases Progression Markers (MARKERS-NDD) · PMID 42633445 Maladie d’Alzheimer Ralentissement de la progression · Immunomodulation · Thérapie génique Publication PubMed Voir la publication source Aging and Alzheimer's disease are complex processes marked by continuous neuronal loss, disrupted neural networks, and… IBRO neuroscience reports 2026-09-03 16:32:06 Source
How Do Patients with Chronic Pain Benefit from a Peer-Supported Pain… Piloting a Novel Peer Support Pain Self-Management Intervention (Project CONNECT) · PMID 28025… Myopathies Traitement symptomatique Publication PubMed Voir la publication source Peer support is a novel and under-studied approach to the management of chronic pain. This study's purpose was to uncov… Pain medicine (Malden, Mass.) 2026-09-03 16:32:00 Source
Decade-long persistence of CD19 CAR T cells in B cell lymphomas. anti-CD19 CAR-T cells · PMID 42575986 Lupus · Myopathies · Sclérose en plaques · Lupus Ralentissement de la progression · Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source Chimeric antigen receptor (CAR) T cell therapy induces durable remissions in lymphoid malignancies, yet the extent and… Nature medicine 2026-09-03 16:31:59 Source
Long-term outcomes of anti-CD19 CAR T cell therapy in refractory myas… anti-CD19 CAR-T cells · PMID 42628528 Lupus · Myopathies · Sclérose en plaques · Lupus Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source Anti-CD19 CAR T cell therapy represents an emerging therapeutic approach for generalized, treatment-refractory myasthen… Cell reports. Medicine 2026-09-03 16:31:59 Source
Very unusual extremely high ferritin with cytokine release syndrome i… rapcabtagene autoleucel · PMID 38697457 Lupus Immunomodulation · Thérapie cellulaire Publication PubMed Voir la publication source Chimeric antigen receptor (CAR) T cell therapy is an immunotherapy that has resulted in tremendous progress in the trea… Clinica chimica acta; international journal of clinica… 2026-09-03 16:31:58 Source
A retrospective study of irreversible electroporation for tumors adja… EVALHEP — Evaluation of the Ablation of Hepatic Lesions by Electroporation · PMID 39328209 Cancer Ralentissement de la progression · Traitement symptomatique Publication PubMed Voir la publication source Irreversible electroporation has been proved as a feasible and safe method against tumor in liver. However, few studies… Frontiers in oncology 2026-09-03 16:31:56 Source
Irreversible electroporation for liver cancer ablation: A meta analys… EVALHEP — Evaluation of the Ablation of Hepatic Lesions by Electroporation · PMID 35012834 Cancer À vérifier Publication PubMed Voir la publication source To evaluate the efficacy and safety of IRE in the treatment of hepatic malignant tumors, especially the damage to the g… European journal of surgical oncology : the journal of… 2026-09-03 16:31:56 Source
Irreversible electroporation versus radiofrequency ablation for malig… EVALHEP — Evaluation of the Ablation of Hepatic Lesions by Electroporation · PMID 35936662 Cancer À vérifier Publication PubMed Voir la publication source Irreversible electroporation (IRE) is a nonthermal ablation technique for the treatment of malignant liver tumors. IRE… Journal of interventional medicine 2026-09-03 16:31:56 Source
Herb-derived immunometabolic modulators: traditional Chinese medicine… Huayu Jiedu Formula (FTFY-919) Granules · PMID 42363193 Cancer Remyélinisation indirecte / réparation · Immunomodulation Publication PubMed Voir la publication source Traditional Chinese Medicine (TCM) has long been applied in oncology to "support vital Qi and eliminate pathogenic fact… Chinese medicine 2026-09-03 16:31:54 Source
Clinical Heterogeneity in Vestibular Migraine Diagnosed Using Bárány… Videonystagmography and Vestibular Migraine · PMID 42683798 Migraine Traitement symptomatique · Thérapie génique Publication PubMed Voir la publication source Vestibular migraine (VM) is a common cause of episodic vertigo with heterogeneous presentations. Some VM patients show… Journal of clinical neurology (Seoul, Korea) 2026-09-03 16:31:53 Source
Exploration — prudence

Pistes exploratoires 0

Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.

Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
Molécule / élément Maladie / population Objectif Phase / stade Statut / preuve Mécanisme / résumé Source Détail
Aucune piste exploratoire ne correspond aux filtres.